First Horizon Advisors Inc. Grows Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

First Horizon Advisors Inc. grew its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 25.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,486 shares of the company’s stock after acquiring an additional 298 shares during the period. First Horizon Advisors Inc.’s holdings in U.S. Physical Therapy were worth $126,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Silvercrest Asset Management Group LLC bought a new position in U.S. Physical Therapy during the 1st quarter valued at approximately $8,158,000. Harbor Capital Advisors Inc. lifted its stake in U.S. Physical Therapy by 292.5% in the second quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock worth $701,000 after acquiring an additional 5,652 shares during the period. Vanguard Group Inc. boosted its holdings in U.S. Physical Therapy by 1.0% in the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after acquiring an additional 10,175 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in U.S. Physical Therapy by 5.8% in the first quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company’s stock valued at $1,423,000 after acquiring an additional 696 shares in the last quarter. Finally, Advisors Asset Management Inc. raised its holdings in U.S. Physical Therapy by 78.4% in the 1st quarter. Advisors Asset Management Inc. now owns 1,056 shares of the company’s stock worth $119,000 after purchasing an additional 464 shares in the last quarter.

U.S. Physical Therapy Trading Up 0.9 %

Shares of NYSE USPH opened at $97.83 on Friday. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a 50-day moving average of $85.22 and a 200 day moving average of $90.83. The stock has a market cap of $1.48 billion, a P/E ratio of 104.07, a price-to-earnings-growth ratio of 4.38 and a beta of 1.38.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.80%. U.S. Physical Therapy’s payout ratio is 187.23%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the transaction, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. The trade was a 19.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the sale, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,896 shares of company stock valued at $656,940 in the last ninety days. 1.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on USPH shares. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, Barrington Research restated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.